Albert Hsia, PhD

 

Albert Hsia is a Partner at iXLife Capital, where he supports the maturation of laboratory spinoffs into robust companies.  Prior to joining iXLife, he was the founding employee, program director, and head of business development at Synta Pharmaceuticals, where he was a key member of the team that built the company from startup to IPO and Phase 3, through acquisition, in-licensing, internal discovery and development, and alliances with leading pharmaceutical companies.  Prior to joining Synta, Dr. Hsia held research roles at the French National Center for Scientific Research (CNRS) and at Harvard Medical School.  He received his Ph.D. in neuroscience at U.C. San Francisco and his B.A. in chemistry and physics at Harvard University.

 

[ Back to Team ]